Centessa Pharmaceuticals plc (CNTA) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 3.39B |
| Enterprise Value | 3.34B |
| P/E Ratio | -22.57 |
| PEG Ratio | 3.13 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 12.66 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -23.65 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.39 |
| Return On Equity | -0.6 |
| Revenue | 15M |
| Revenue/Share | 0 |
| Gross Profit | 15M |
| EBITDA | -183.33M |
| Net Income | -197.53M |
| Diluted EPS | -1.46 |
| Total Cash | 276.59M |
| Total Cash/Share | 1.8 |
| Total Debt | 7.37M |
| Total Debt/Equity | 0.02 |
| Current Ratio | 9.53 |
| Book Value Per Share | 3.17 |
| 52-Week Change | 209.08 |
| 52-Week High | 40.26 |
| 52-Week Low | 12.74 |
| Moving Average 50 Days | 39.67 |
| Moving Average 200 Days | 29.08 |
| Average Volume | 2.79M |
| Shares Outstanding | 154.73M |
| % Held by Institutions | 109.52 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |